Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Frequency of Arterial Thromboemobolic Events in Patients with Cancer Associated Venous Thromboembolism

Doaa Attia, MD, Xuefei Jia, MS, Mailey L Wilks, DNP, MSN, APRN, Barbara Tripp, APRN, CNS, Christopher D'Andrea, PA-C, Keith R McCrae, MD, Alok A Khorana, MD, Dana E Angelini, MD

Blood (2020) 136 (Supplement 1): 37.

https://doi.org/10.1182/blood-2020-136101

Published: 2020

Journal Articles

Risk of Recurrent Venous Thromboembolism and Bleeding in Patients with Cancer Associated Thrombosis

Doaa Attia, MD, Xuefei Jia, MS, Mailey L Wilks, DNP, MSN, APRN, Barbara Tripp, APRN, CNS, Christopher D'Andrea, PA-C, Keith R McCrae, MD, Alok A Khorana, MD, Dana E Angelini, MD

Blood (2020) 136 (Supplement 1): 18.

https://doi.org/10.1182/blood-2020-142805

Published: 2020

Journal Articles

Bleeding Outcomes of Gastrointestinal Cancer Patients Treated with Direct Oral Anticoagulants Vs. Low Molecular Weight Heparin

Dana E Angelini, MD, Doaa Attia, MD, Wei Wei, MS, Mailey L Wilks, DNP, MSN, APRN, Barbara Tripp, APRN, CNS, Christopher D'Andrea, PA-C, Keith R McCrae, MD, Alok A Khorana, MD

Blood (2020) 136 (Supplement 1): 27.

https://doi.org/10.1182/blood-2020-136757

Published: 2020

Journal Articles

Clinical Outcomes of Cancer-Associated Thrombosis Beyond 6 Months of Anticoagulation

Shyam K Poudel, Chandana A Reddy, MS, Deborah Y Park, BS, Mailey L Wilks, CNP, MSN, APRN, Vicki Pinkava, MSBS, PA-C, Meghan O'Brien, MS, ANP-BC, Barbara Tripp, CNS, Jung-Min Song, RN,CNS, Keith R McCrae, MD, Alok A Khorana, MD, Dana E Angelini, MD

Blood (2019) 134 (Supplement_1): 3458.

https://doi.org/10.1182/blood-2019-127581

Published: 2019

Journal Articles

Clinical Outcomes with Direct Oral Anticoagulants Compared to Low Molecular Weight Heparins in the Treatment of Cancer-Associated Venous Thromboembolism

Deborah Y. Park, BS, Shyam K. Poudel, MD, Xuefei Jia, MS, Mailey Lynn Wilks, CNP, MSN, APRN, Vicki Pinkava, MSBS, PA-C, Meghan O'Brien, MS, ANP-BC, Barbara Tripp, CNS,AOCN, Jung-Min Song, RN,CNS, Keith R. McCrae, MD, Dana E. Angelini, MD, Alok A. Khorana, MD

Blood (2018) 132 (Supplement 1): 1237.

https://doi.org/10.1182/blood-2018-99-111897

Published: 2018

Journal Articles

Clinical Outcomes of Isolated Distal Deep Vein Thrombosis Associated with Cancer: The Cleveland Clinic Experience

Shyam K. Poudel, MD, Xuefei Jia, MS, Deborah Y. Park, BS, Mailey Lynn Wilks, CNP, MSN, APRN, Vicki Pinkava, MSBS, PA-C, Meghan O'Brien, MS, ANP-BC, Barbara Tripp, CNS, AOCN, Jung-Min Song, RN, CNS, Keith R. McCrae, MD, Alok A. Khorana, MD, Dana E. Angelini, MD

Blood (2018) 132 (Supplement 1): 4809.

https://doi.org/10.1182/blood-2018-99-114897

Published: 2018

Journal Articles

A Phase 1 Trial of Imatinib Mesylate with Daunorubicin and Cytarabine for Patients with C-Kit Positive Relapsed AML.

Anjali Advani, MD, Edward A. Copelan, MD, Ronald Sobecks, MD, Mikkael A Sekeres, MD, MS, Jennifer Bates, Mary Lynn Rush, Barbara Tripp, Elysa Noon, PhD, Matthew Howard, MD, Tao Jin, Eric Hsi, MD, Matt Kalaycio, MD

Blood (2008) 112 (11): 955.

https://doi.org/10.1182/blood.V112.11.955.955

Published: 2008

Journal Articles

A Phase 1 Trial of Imatinib Mesylate in Combination with Daunorubicin and Cytarabine for Patients for C-kit Positive Relapsed Acute Myeloid Leukemia (AML).

Anjali S. Advani, MD, Ronald Sobecks, MD, Mikkael A. Sekeres, MD, Ed Copelan, MD, Jennifer Bates, Barbara Tripp, RN, August Salvado, MD, Matt Kalaycio, MD

Blood (2007) 110 (11): 906.

https://doi.org/10.1182/blood.V110.11.906.906

Published: 2007

Journal Articles

The Relationship between Weekend Admissions and Outcome in Older Adults with Acute Myelogenous Leukemia (AML).

Ahmed Al-Hazzouri, MD, Lisa Rybicki, Matt Kalaycio, MD, Stacey Brown, Hyo Sook Han, MD, Brad Pohlman, MD, Anjali Advani, MD, Barbara Tripp, Ronald Sobecks, MD, Mikkael Sekeres, MD

Blood (2004) 104 (11): 3140.

https://doi.org/10.1182/blood.V104.11.3140.3140

Published: 2004

NARROW

Frequency of Arterial Thromboemobolic Events in Patients with Cancer Associated Venous Thromboembolism

Risk of Recurrent Venous Thromboembolism and Bleeding in Patients with Cancer Associated Thrombosis

Bleeding Outcomes of Gastrointestinal Cancer Patients Treated with Direct Oral Anticoagulants Vs. Low Molecular Weight Heparin

Clinical Outcomes of Cancer-Associated Thrombosis Beyond 6 Months of Anticoagulation

Clinical Outcomes with Direct Oral Anticoagulants Compared to Low Molecular Weight Heparins in the Treatment of Cancer-Associated Venous Thromboembolism

Clinical Outcomes of Isolated Distal Deep Vein Thrombosis Associated with Cancer: The Cleveland Clinic Experience

A Phase 1 Trial of Imatinib Mesylate with Daunorubicin and Cytarabine for Patients with C-Kit Positive Relapsed AML.

A Phase 1 Trial of Imatinib Mesylate in Combination with Daunorubicin and Cytarabine for Patients for C-kit Positive Relapsed Acute Myeloid Leukemia (AML).

The Relationship between Weekend Admissions and Outcome in Older Adults with Acute Myelogenous Leukemia (AML).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only